Is Intuitive Surgical (ISRG) A Buy Ahead of Q1 Earnings Announcement?

ISRG

Well-known medical instruments company Intuitive Surgical (ISRG - Free Report) is set to report first-quarter earnings results on Tuesday after the close. Intuitive Surgical, a Zacks Rank #3 (Hold), has missed the earnings mark in two of the last four quarters. But with shares roaring back to life in recent weeks, is ISRG a buy?

Intuitive Surgical is expected to post a profit of $1.18/share, which would reflect growth of 4.4% versus the same quarter last year. Estimates for the quarter have increased 0.85% over the past 60 days. Revenues are projected to climb 6.5% to $1.58 billion.

The company’s surgical systems enable physicians to enhance access to patients. ISRG offers the da Vinci Surgical System using a minimally invasive surgery approach.

ISRG is part of the Zacks Medical – Instruments industry, which ranks in the top 44% out of all Zacks Ranked Industries. Shares remain relatively overvalued based on standard metrics.

Highest Returns for Any Asset Class

It’s not even close. Despite ups and downs, Bitcoin has been more profitable for investors than any other decentralized, borderless form of money.

No guarantees for the future, but in the past three presidential election years, Bitcoin’s returns were as follows: 2012 +272.4%, 2016 +161.1%, and 2020 +302.8%. Zacks predicts another significant surge in months to come.

Hurry, Download Special Report – It’s FREE >>